Cell-Based Models for Neurodegeneration Study and Use in Screening

Informazioni relative al progetto

CENSUS

ID dell’accordo di sovvenzione: 730678

DOI

10.3030/730678

Progetto chiuso

Data della firma CE 13 Settembre 2016

Data di avvio 1 Ottobre 2016

Data di completamento 30 Settembre 2019

Finanziato da

• Horizon 2020 Framework Programme

Costo totale

€ 2 561 828,75

Contributo UE

€ 1 793 280,13

Coordinato da

AvantiCell Science Ltd
United Kingdom

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Demonstrators, pilots, prototypes (2)

CNS cell product and product information for single cell-type model

Produce Product Information Sheet describing 3D+ neural single-cell product.

CNS cell product and product information for dual cell-type model

Assemble and process-test dual-cell 3D+ production SOPs. Produce Product Information Sheet describing 3D+ neural dual-cell product

Documents, reports (1)

Documents defining technical performance and applications of 3D printed cell models

1. Standard Operating Procedures for 3D neurodegenerative therapeutic screening will be written. (M19) 2. Manufacturing protocols for 3D neural model(s) will be developed and ratified. (M21) 3. Materials and material supply arrangements will be consolidated (M21) 4. CNS cell product and product information for a single cell-type model will be produced. (M21) 5. CNS cell product and product information for a dual cell-type model will be produced. (M24) 6. The Deliverable outcome will be commercially-ready neurodegenerative screening services in 2D and 3D formats. (M24)